1/ This paper is very interesting:
https://www.nature.com/articles/s41598-019-38808-z
It summarises some of the literature on the aerosolisation of particles during speech and reports impact of increasing speech volume on aerosolisation. Here's my summary:
https://www.nature.com/articles/s41598-019-38808-z
It summarises some of the literature on the aerosolisation of particles during speech and reports impact of increasing speech volume on aerosolisation. Here's my summary:
2/
smaller particles (~1μm) are aerosolised during breathing and talking (N.B. #COVID19 virus is 100-160 nm in size so these particles are big enough to carry the virus)

3/
these smaller particles are potentially more infectious than the larger particles (~50μm) produced during coughing and sneezing, because they stay in the air for longer
smaller particles have more chance of penetrating deeper into the lungs


4/
speech can release a larger numbers of particles compared to coughing (counting aloud produces 2-10x more particles than 1 cough)
there is a linear correlation: increasing particle emission with increasing speech volume


5/
particles are the same size (~1μm) regardless of speech volume
on average speaking loudly resulted in 10x more particle emission than speaking quietly
some participants were superemitters but there were no trends for gender, age, BMI



6/
Hypthesised mechanism of action: vocal fold vibration and adduction at the larynx resulting in a 'fluid-film burst' mechanism and particle emission

7/
My question is: should we be wearing FFP3 for all SLT assessment and interventions with COVID-19 suspected and positive patients?
What do #wespeechies think?
My question is: should we be wearing FFP3 for all SLT assessment and interventions with COVID-19 suspected and positive patients?
What do #wespeechies think?